Literature DB >> 8188614

Tumor necrosis factor-alpha, a new tumor promoter, engendered by biochemical studies of okadaic acid.

H Fujiki1, M Suganuma.   

Abstract

Okadaic acid is a potent tumor promoter on mouse skin and in rat glandular stomach, and an inhibitor of PP-1 and PP-2A. How okadaic acid biochemically induces tumor promotion in these tissues was reviewed. Okadaic acid bound to a catalytic subunit of PP-1 and PP-2A and induced hyperphosphorylation of proteins, such as vimentin, cytokeratins, HSP 27, and tumor suppressor gene products. Since one of the okadaic acid class compounds, microcystin-LR, induced tumor promotion in rat liver, the okadaic acid pathway mediated through inhibition of PP-1 and PP-2A is seen to be a general biochemical process of tumor promotion in various organs. The biochemical mimicry of okadaic acid by TNF-alpha led us to find that TNF-alpha is an endogenous tumor promoter. The study of tumor promotion in two-stage carcinogenesis experiments with the okadaic acid class of compounds engendered a new tumor promoter applicable to human cancer development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188614     DOI: 10.1093/oxfordjournals.jbchem.a124282

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

Review 1.  Regulation of p53 by protein kinase C during multi-stage carcinogenesis.

Authors:  L Magnelli; V Chiarugi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  The promoting effect of tumour necrosis factor alpha in radiation-induced cell transformation.

Authors:  R F Guo; Y F Gong
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

3.  Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.

Authors:  M Suganuma; S Okabe; E Sueoka; R Nishiwaki; A Komori; N Uda; K Isono; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

Review 4.  Tumor promoters: from chemicals to inflammatory proteins.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2013-06-12       Impact factor: 4.553

5.  Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.

Authors:  H K Kole; M S Smyth; P L Russ; T R Burke
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

6.  Risk factors for lung cancer among Northern Thai women: epidemiological, nutritional, serological, and bacteriological surveys of residents in high- and low-incidence areas.

Authors:  K Nakachi; P Limtrakul; P Sonklin; O Sonklin; C T Jarern; S Lipigorngoson; K Arai; Y Sone; K Imai; K Suga; S Matsuyama; H Shimizu; T Takahashi; M Suttajit
Journal:  Jpn J Cancer Res       Date:  1999-11

7.  Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.

Authors:  Iman A F Azmy; Saba P Balasubramanian; Anthony G Wilson; Timothy J Stephenson; Angela Cox; Nicola J Brown; Malcolm W R Reed
Journal:  Breast Cancer Res       Date:  2004-05-24       Impact factor: 6.466

8.  Silica nanoparticles induce endoplasmic reticulum stress response, oxidative stress and activate the mitogen-activated protein kinase (MAPK) signaling pathway.

Authors:  Verena Christen; Magdalena Camenzind; Karl Fent
Journal:  Toxicol Rep       Date:  2014-11-04

9.  Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-alpha release in mouse lung tissues.

Authors:  E Sueoka; S Nishiwaki; S Okabe; N Iida; M Suganuma; I Yano; K Aoki; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1995-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.